Downstream Processing Market to Reach US$ 25,800 Mn by 2022
Posted by pradnya86 on May 21st, 2018
Downstream processing is used to manufacture antibiotics, antibodies, hormones, vaccines and also used for the production of industrial enzymes. In downstream processing, the purification and recovery of biosynthetic products is done that are derived from natural sources such as tissues of animals and plants. The growth of the downstream processing market is fuelled by the ever growing demand for biopharmaceuticals and increasing R&D spending on the development of such products. However, the high cost of the instruments involved in downstream processing and a dearth of skilled workforce is hampering the growth of this market.
The global downstream processing market is slated to touch a value of about US$ 25,800 Mn in the year 2022 and display a robust CAGR during the assessment period.
4 Forecast Highlights on Global Downstream Processing Market
Request to Sample Report - https://www.futuremarketinsights.com/reports/sample/rep-gb-5070
The report has also included the profiles of some of the leading companies in the downstream processing market like Sartorius Aktiengesellschaft, Repligen Corporation, Merck & Co Inc., Thermo Fisher Scientific, Inc., Eppendorf AG, General Electric Company, Corning Incorporated, 3M Company, Lonza Group Ltd. and Danaher Corporation.
Top Searches - Trending Searches - New Articles - Top Articles - Trending Articles - Featured Articles - Top Members
Copyright © 2019 Uberant.com654,092 total articles and counting.